Stoke Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$31.00

+0.74 (+2.45%)

As of Jun 21, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +61.8% upside

Low Target $29.72

Average Target $50.17

High Target $68.67

Current Price $31.00

Current
$31.00

Target
$50.17

$29.72 $50.17 avg $68.67

Scenario Analysis

Bear Case

$29.72

-4.1%

Low target

Base Case

$50.17

+61.8%

Avg target

Bull Case

$68.67

+121.5%

High target

Risk/Reward

29.4x

Highly favorable

Price in Context

52-Week High

$40.22

-22.9% from high

52-Week Low

$11.17

+177.5% from low

Target vs 52W High

$50.17

+24.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+188.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.9%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.4%